CTRI/2016/10/007386已完成2 期
A double-blind, placebo controlled, randomized, clinical study to evaluate the efficacy and safety of test formulations
ITC LIFE SCIENCES AND TECHNOLOGY CENTER0 个研究点目标入组 120 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •> Male or female dyspepsia subjects aged between 18 to 65 years of age at the time of screening visit.
- •> Subject clinically diagnosed with dyspepsia.
- •> Subject must be able to understand and complete questionnaires.
- •> Subject must be willing to or likely to comply with all study requirements.
- •> Subject willing to voluntarily sign the informed consent form.
- •> Subject meeting all the laboratory parameters set forth to qualify to enroll in the study.
排除标准
- •> Use of Proton pump inhibitors (PPIs), H2 receptor antagonists and prokinetics.
- •> Subjects with Acute peptic ulcer, severe GERD and/or ulcer complications.
- •> Systemic glucocorticoids or non-steroidal anti-inflammatory drugs (NSAIDs) including COX-2-inhibitors.
- •> Complications of gastroesophageal reflux disease which in the opinion of the Investigator may preclude trial participation.
- •> Severe or unstable systemic disease/ disorder.
- •> Intake of psychotropic medication, dyspepsia-inducing drugs, and anticholinergic agents.
- •> Diagnosis of any other clinically significant medical condition or serious gastrointestinal disorder which in opinion of investigator may jeopardize subjectââ?¬•s safety and preclude trial participation.
- •> Subjects with medical history of surgery of esophagus, stomach or duodenum.
- •> Abuse of drugs or alcohol confirmed by history.
- •> Pregnant or nursing female patients; Non-pregnant, non-lactating female patients of childbearing potential who are not using reliable method of contraception.
- •> Subjects with deteriorating health status at the time of enrollment.
- •> Autoimmune diseases, recent blood donation, immunodeficiency disease (e.g., human immunodeficiency virus [HIV] infection and hepatitis B)
- •> Currently participating or having participated in another clinical trial during the last 3 months prior to the beginning of this study.
- •> Subjects unwilling or unable to comply with the study procedures.
- •> History of allergy to any component of the study product.
研究者
相似试验
已完成
不适用
Clinical study to measure the effect of natural product in muscle pain and related swelling and stress in healthy subjects.CTRI/2022/06/043370AureaBiolabs Private Limited110
招募中
2 期
This is a double blind study where Curcuma caesia is compared to Placebo in weight management.CTRI/2017/03/008045Sami Labs Limited60
尚未招募
不适用
A clinical study to evaluate the safety and to understand the efficacy of FenuSMART on sexual functions and menstrual problems in womeCTRI/2018/09/015614Akay Flavours and Aromatics Private Limited
进行中（未招募）
1 期
Erythropoieitn in Friedreich AtaxiaMedDRA version: 14.1Level: PTClassification code 10008025Term: Cerebellar ataxiaSystem Organ Class: 10029205 - Nervous system disordersFRIEDREICH ATAXIAEUCTR2011-006156-37-ITIVERSITA' DEGLI STUDI DI NAPOLI FEDERICO II
尚未招募
不适用
A clinical study to evaluate the safety and efficacy of ABE-0520 on middle-aged male subjects with androgen deficiencyCTRI/2021/01/030391Akay Natural Ingredients Pvt Ltd